DR. M.A AHAD ATHAR MD NPI 1518166818

NPI Information

  • NPI: 1518166818
  • Provider Name: DR. M.A AHAD ATHAR, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5236 W UNIVERSITY DR STE 1000
    MCKINNEY, TX
    ZIP 75071
  • Phone: (972) 542-8609

Map and Directions

Get Directions

NPI Details

DR. M.a Ahad Athar, MD is a hematology and oncology internal medicine in Mckinney, TX with 19 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. M.a Ahad Athar, MD NPI is 1518166818. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:2007

The provider's business location address is:

5236 W UNIVERSITY DR STE 1000
MCKINNEY, TX
ZIP 75071-106
Phone: (972) 542-8609

The NPI 1518166818 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Magnesium level (HCPCS:83735)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of chest without contrast (HCPCS:71250)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session (HCPCS:G6015)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 7/16/2007 and was last updated on 10/8/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineN6149TEXASNo
2207RH0003XInternal MedicineHematology & OncologyN6149TEXASYes
3207RX0202XInternal MedicineMedical OncologyN6149TEXASNo
4390200000XStudent in an Organized Health Care Education/Training ProgramNo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1322620101MEDICAIDTEXAS
2P01415856OTHERTEXASRAILROAD MEDICARE

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.